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Abstract
Background: The aim of this study was to estimate the prevalence and distribution of type 2 diabetes and to determine the
status of type 2 diabetes awareness, treatment, and control in Xinjiang, China. Our data came from the Cardiovascular Risk
Survey (CRS) study designed to investigate the prevalence and risk factors for cardiovascular diseases in Xinjiang from
October 2007 to March 2010. A total of 14 122 persons (5583 Hans, 4620 Uygurs, and 3919 Kazaks) completed the survey
and examination. Diabetes was defined by the American Diabetes Association 2009 criteria.
Methodology/Principal Findings: Overall, 9.26% of the Han, 6.23% of the Uygur, and 3.65% of the Kazak adults aged
$35 years had diabetes. Among diabetes patients, only 53.0% were aware of their blood glucose level, 26.7% were taking
hypoglycemic agents, and 10.4% achieved blood glucose control in Han, 35.8% were aware of their blood glucose level,
7.3% were taking hypoglycemic agents, and 3.13% achieved blood glucose control in Uygur, and 23.8% were aware of their
blood glucose level, 6.3% were taking hypoglycemic agents, and 1.4% achieved blood glucose control in Kazak, respectively.
Conclusions/Significance: Our results indicate that diabetes is highly prevalent in Xinjiang. The percentages of those with
diabetes who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop
national strategies to improve prevention, detection, and treatment of diabetes in Xinjiang, the west China.
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Introduction
Type 2 diabetes mellitus (T2DM) is now a global health
problem and a growing cause of death and disability, mainly
through cardiovascular diseases [1–3]. The International Diabetes
Federation has predicted that the number of individuals with
diabetes will increase from 240 million in 2007 to 380 million in
2025 and further increase to 439 million in 2030 [4–5].
In China, the prevalence of diabetes increased from 1% in 1980
to 5.5% in 2001[6] with much higher rates in urban areas such as
Shanghai [7], Hong Kong and Taiwan [8]. Xinjiang, a province
of China, is part of the ancient Silk Road and borders eight
countries including Russia, Kazakhstan, Kirghizastan, Tajikistan,
Pakistan, Monogolia, India and Afghanistan. There are more than
13 ethnic groups living in this area. Among them, the Uygur
people account for 46%, Han account for 40%, and Kazak
account for 7%. Although the racial/ethnic disparities associated
with type 2 diabetes are well known [9], there are limited data on
the prevalence of diabetes among Han, Uygur, and Kazak
population in Xinjiang. Awuti reported the prevalence of diabetes
in Uygur population was 9.0% in 2010 [10]. Tao reported the
prevalence of diabetes was 8.16% in Uygur and 1.47% in Kazak
population in 2008, respectively [11]. However, they did not
report the awareness, treatment, and control of diabetes in these
two ethnics population. Furthermore, these two researches
enrolled very small samples and did not use a province-wide
population-based representative random sample. To better
understand the prevalence, awareness, treatment, and control of
type 2 diabetes in Han, Uygur and Kazak population in Xinjiang,
an epidemiological study enrolled 14 618 participants was
conducted from 2007 to 2010, which is expected to provide a
comprehensive update to the results of the previous studies.
Methods
Ethics Statement
The present study was conducted in accordance with the
Declaration of Helsinki guidelines, and written informed consent
was obtained from each individual according to a protocol
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of Xinjiang Medical University.
Subjects
The subjects came from the Cardiovascular Risk Survey (CRS)
described in the previous study [12–14]. Briefly, The Cardiovas-
cular Risk Survey (CRS) study is a multiple-ethnic, community-
based, cross-sectional study designed to investigate the prevalence
and risk factors for cardiovascular diseases and to determine the
genetic and environmental contributions to atherosclerosis,
coronary artery disease (CAD) and cerebral infarction (CI) of
Chinese Han, Uygur, and Kazakh population in Xinjiang of west
China from October 2007 to March 2010. We used a stratified
sampling method to select a representative sample of the general
population of Chinese Hans, Uygurs, and Kazakhs of this area.
Seven cities (Urumqi, Kelamayi, Hetian, Zhaosu, Fukang,
Tulufan, and Fuhai) were chosen and, based on the government
record of registered residence, one participant was randomly
selected from each household. In this way, a total of 14 618
participants (5 757 Hans, 4 767 Uygurs, and 4 094 Kazakhs), were
randomly selected from 26 villages of these seven cities and were
invited to participate. Those whose data were incomplete were
excluded. Finally, 14 122 persons (5583 Hans, 4620 Uygurs, and
3919 Kazaks) completed the survey and examination. The overall
response rate was 96.61%.
We defined diabetes by using the American Diabetes Associ-
ation (ADA) 2009 criteria [15] (fasting plasma glucose
$7.0 mmol/L [$126 mg/dL]) or self-reported current diabetes
treatments in the survey. Awareness of diabetes was defined as self
report of any prior diagnosis of diabetes by a health care
professional among the population defined as having diabetes.
Treatment of diabetes was defined as use of a prescription
medication for management of diabetes at the time of the
interview. Control of diabetes was defined as pharmacological
treatment of diabetes associated with an average fasting GLU level
,7.0 mmol/L [,126 mg/dL].
Data collection was conducted in examination centers at local
hospital in the participants’ residential area. At the time of the in-
person interview, a 5-mL fasting blood samples (at least fasting
8 hours) were collected with an EDTA vacutainer tube. The
samples were kept in a portable Styrofoam box with ice packs (0–
4uC) and were processed within 4 h. All samples were stored at
280uC immediately after processing. We measured the concen-
tration of fasting glucose using equipment for chemical analysis
(Dimension AR/AVL Clinical Chemistry System, Newark, NJ,
USA) employed by the Clinical Laboratory Department of the
First Affiliated Hospital of Xinjiang Medical University.
During clinic or home visits, trained research staff administered
a standard questionnaire. Information on demographic charac-
teristics-including age, gender, education, address, ethnicity,
occupation, and household income-was collected. The interview
included questions related to the diagnosis and treatment of
diabetes. Information on the awareness of, and drug treatment
and lifestyle modification for, diabetes was also obtained.
Data Management and Statistical Analysis
All questionnaire data was double-entered and cross-validated
usingEpiDataversion3.1(EpiDataAssociation,Odense,Denmark).




test was used to explore associations in categorical data. Student’s t-
test was used to compare two means in numerical data. Two tailed
tests were performedwith the significance level at 0.05.
Results
Prevalence
The characteristics of study participants were shown in table 1.
As shown in table 2, the prevalence of T2DM was 9.26% in Han,
6.23% in Uygur, and 3.65% in Kazak population, respectively.
The overall prevalence of T2DM was the highest in Han and the
lowest in Kazak among these three ethnics. In each ethnic, the
overall prevalence of T2DM was higher among men than among
women. For every age group up to 74 years, the prevalence of
T2DM increased with age in both men and women. The
prevalence of obesity in Kazak population was higher than that
in Han or in Uygur population.
Mean Glucose Levels
Table 3 presents gender- and ethnic-specific mean glucose
values for 3 subgroups defined by diabetes status. Overall, the
average glucose levels for no-diabetes subjects were 2.33, 3.30, and
3.18 mmol/L lower than the corresponding values for those with
treated diabetes, and 4.75, 5.01, 5.31 mmol/L lower than the
corresponding values for those with untreated diabetes in Han,
Uygur, and Kazak population, respectively. In contrast, the overall
levels of glucose differences between treated and untreated
participants with diabetes were only 2.42, 1.71, and 2.13 mmol/
L in Han, Uygur, and Kazak population, respectively.
Awareness, Treatment, and Control of Diabetes
Table 4 provides the percentages of participants with diabetes
who were aware of their diabetes status, who were being treated
with hypoglycemic medications, and who had their diabetes
controlled. Overall, in Han ethnic, 53.0% of those with diabetes
were aware of their diagnosis, only 26.7% were taking prescribed
medication to lower their blood glucose, and only 10.44%
achieved blood glucose control; in Uygur ethnic, 35.0% of those
with diabetes were aware of their diagnosis, only 7.3% were taking
prescribed medication to lower their blood glucose, and only
3.13% achieved blood glucose control; and in Kazak ethnic,
Table 1. Participant Characteristics.







Age, years 52.6612.7 50.7613.0 48.7611.7
Height, cm 163.268.5 159.868.5 162.768.7
Weight, Kg 67.2611.9 66.1612.9 70.6615.1
BMI, kg/m
2 25.163.5 25.864.4 26.664.8
SBP, mmHg 132.9619.9 131.5621.2 140.4625.1
DBP, mmHg 85.0615.5 80.1614.9 88.5619.7
Waist Circumference, cm 86.8610.3 88.2612.3 88.3613.3
Hip Circumference, cm 95.867.4 97.7610.0 99.669.7
Sex, women, n (%) 2888 (51.7) 2670 (57.8) 2025 (51.7)
Smoking, n (%) 1751 (31.4) 872 (18.9) 1398 (35.7)
Alcohol drinking, n (%) 1059 (19.0) 457 (9.9) 570 (14.5)
Diabetes, n (%) 517 (9.3) 288 (6.2) 143(3.6)
Treated diabetes, n (%) 138 (2.5) 21 (0.5) 9 (0.2)
Continuous variables are presented as mean6SD, whereas categorical variables
are presented as counts and percentages.
doi:10.1371/journal.pone.0035270.t001
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6.3% were taking prescribed medication to lower their blood
glucose, and only 1.4% achieved blood glucose control. Among
these three ethnics, the awareness, treatment, and control of
diabetes was the highest in Han ethnic but the lowest in Kazak
ethnic, respectively.
More women (57.7%) were aware of their diabetes than were
men (48.9%), and the treatment and control were also more
common among women than among men in Han ethnic.
However, more men (27.8%) were aware of their diabetes than
were women (15.2%), and the treatment and control were also
more common among men than among women in Kazak ethnic.
Although there was not difference in awareness and treatment of
diabetes between men and women in Uygur population, the
control rate was higher in men (5.34%) than that in women
(1.27%). Less than one fourth (23.0%) of men reported that they
were taking hypoglycemic medication for their diabetes in Han,
and the percentage was much lower for men in Uygur (6.9%) and
in Kazak population (8.2%), respectively. Only 31.0% of Han
women reported that they were being treated for their diabetes.
Only 7.6% of Uygur women and 2.2% of Kazak women with
diabetes reported that they were being treated for their diabetes.
Table 2. Prevalence of diabetes in adult population, aged $35 years, in Xinjiang, 2007–2010.
Age, y Men Women Total
N Diabetes [n, (%)] Obesity [n, (%)] N Diabetes [n, (%)] Obesity [n, (%)] N Diabetes [n, (%)] Obesity [n, (%)]
Han ethnic
35–44 986 64(6.49) 201(20.4) 966 25(2.59) 62(6.4) 1952 89 (4.56) 263(13.5)
45–54 644 79(12.27) 145(22.5) 676 47(6.95) 91(13.5) 1320 126 (9.55) 236(17.9)
55–64 444 37(8.33) 113(25.5) 616 73(11.85) 148(24.0) 1060 110 (10.38) 261(24.6)
65–74 465 71(15.27) 102(21.9) 530 81(15.28) 138(26.0) 995 152 (15.28) 240(24.1)
$75 156 27(17.31) 31(19.9) 100 13(13.00) 22(22.0) 256 40 (15.63) 53(20.7)
Total 2695 278(10.32) 592(22.0) 2888 239(8.28)* 461(16.0) 5583 517(9.26)** 1053(18.9)**
Uygur ethnic
35–44 587 26(4.43) 131(22.3) 1021 22(2.15) 279(27.3) 1608 48 (2.99) 410 (25.5)
45–54 485 28(5.77) 145(29.9) 741 45(6.07) 277(37.4) 1226 73 (5.95) 422 (34.4)
55–64 481 42(8.73) 114(23.7) 573 49(8.55) 193(33.7) 1054 91 (8.63) 307(29.1)
65–74 291 29(9.97) 71(24.4) 273 35(12.82) 84(30.8) 564 64 (11.35) 155(27.5)
$75 106 6(5.66) 16(15.1) 62 6(9.68) 13(21.0) 168 12 (7.14) 29 (17.3)
Total 1950 131(6.72) 477(24.5) 2670 157(5.88) 846(31.7) 4620 288 (6.23) 1323(28.6)
Kazak ethnic
35–44 777 34(4.38) 270(34.7) 871 7(0.80) 162(18.6) 1648 41 (2.49) 432 (26.2)
45–54 509 28(5.50) 207(40.7) 581 20(3.44) 249(42.9) 1090 48 (4.40) 456(41.8)
55–64 355 20(5.63) 142(40.0) 375 11(2.93) 174(46.4) 730 31 (4.25) 316(43.3)
65–74 203 12(5.91) 75(36.9) 168 8(4.76) 64(38.1) 371 20 (5.39) 139(37.5)
$75 50 3(6.00) 18(36.0) 30 0(0.00) 9(30.0) 80 3 (3.75) 27(33.8)
Total 1894 97(5.12) 712(37.6) 2025 46(2.27)* 658(32.5) 3919 143 (3.65) 1370(35.0)
doi:10.1371/journal.pone.0035270.t002
Table 3. Glucose levels in adult population by diabetes status and ethnics in Xinjiang, 2007–2010.
Groups Ethnics
n Han n Uygur n Kazak
No-diabetes (Mean6SD, mmol/L) Men 2417 5.0360.76 1819 4.5960.81 1797 4.9860.77
Women 2649 4.8960.72 2513 4.6660.77 1979 4.9160.72
Total 5066 4.9660.74 4332 4.6360.79 3776 4.9460.75
Untreated diabetes (Mean6SD, mmol/L) Men 214 9.8164.07 122 10.0563.96 89 9.9864.06
Women 165 9.5863.28 145 9.2862.94 45 10.8065.86
Total 379 9.7163.74*# 267 9.6463.46*# 134 10.2564.74*#
Treated diabetes (Mean6SD, mmol/L) Men 64 7.5562.90 9 5.3261.90 8 7.7362.67
Women 74 7.0862.62 12 9.6865.23 1 11.2060.00
Total 138 7.2962.75** 21 7.9364.68** 9 8.1262.75**
doi:10.1371/journal.pone.0035270.t003
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Kazak population achieved blood glucose controlled.
Discussion
In the present study, we found a very high prevalence of diabetes
but a very low rate of awareness, treatment, and control in Han,
Uygur, and Kazak population in Xinjiang. Especially in Uygur and
Kazak population, the percentages of those with diabetes who are
aware, treated, and controlled are unacceptably low. Overall, our
findingsindicate that9.26% ofHan,6.23%ofUygur,and 3.65%of
Kazak people more than 35 years of age in Xinjiang have diabetes.
Several previous large cross-sectional studies have reported the
prevalence ofdiabetes inChina [6,16–18].
Pan et al. reported the prevalence of diabetes was 2.5% in
China in 1994 [16]. Wang reported the prevalence of diabetes was
3.21% in Chinese during 1995–1997 [17]. Gu et al. reported 5.2%
men and 5.8% women in China aged 35 to 74 years had diabetes
in 2001–2002 [6]. Liu et al. found the prevalence of diabetes and
IFG in Chinese adults was 2.7% and 4.9%, respectively, in 2002
[18]. These above studies mainly enrolled Chinese Han
participants. The prevalence of diabetes in the minorities of
China was incompletely investigated. Recently, Tao et al. [11]
investigated the prevalence of diabetes in Uygur and Kazak
population in Xinjiang and found the prevalence of diabetes was
8.16% in Uygur and 1.47% in Kazak population. The prevalence
of diabetes in Uygur was higher and in Kazak was lower than that
of our research, respectively. However, in their study, only 1,571
Uygur and 2,913 Kazak participants were enrolled, and these
subjects can not represent the whole province population for only
three regions were choosen The CRS study considered adults aged
$35 years of Xinjiang and emphasized the geographic and
economic differences between northern and southern regions.
Therefore, the data from the CRS provide a comprehensive
update to the results of Tao et al.
Our results indicated that the prevalence of diabetes among
Uygur and among Kazak in Xinjiang was significantly lower than
that among Han. For the Han ethnic, the prevalence of diabetes
estimated in the present study exceeds that of many developing
countries [19–27] and is similar to that in industrial countries [28–
31]. The overall prevalence of diabetes in US was estimated to be
5.3% in 1976–1980 [28], 8.2% in 1999–2000 [29], and 12.6% in
2005–2006 [30]. In China, the overall prevalence of diabetes was
reported 1.0% in 1980 [32], 2.5% in 1994–1995[16], and 5.5% in
2000–2001[6]. During the past ten years, no further prevalence of
diabetes in China was investigated. Our results indicated that the
prevalence of diabetes of Han was 9.26% during 2007–2010,
which was significantly higher than that of the latest survey in
China.
Furthermore, the percentage of awareness, treatment, and
control of diabetes is unacceptably low in the Han, Uygur and
Kazak adult population, as indicated from the present study,
especially in Uygur and Kazak population. Therefore, a national
diabetes education program should be established to promote
community- and clinic-based blood glucose screening. Physicians
must regularly check their patients’ blood glucose, and a more
aggressive blood glucose-lowering goal and strategy must be
utilized.
Our study has several limitations. Firstly, the CRS provided
only cross-sectional data and did not permit further study of risk
factors for incident diabetes. Secondly, related economic factor
such as household income and social data about people’s
knowledge, attitudes, and beliefs about the factors contributing
to health and disease were unavailable. This limited our ability to
further explore why diabetes were less prevalent among Uygur
and among Kazak than among Han. Finally, in this study, only
fasting plasma glucose level was used to diagnose new cases of
diabetes, this fact may underestimate the prevalence of diabetes.
Conclusion
The present study indicates that the prevalence of diabetes in
Xinjiang, the west China, is very high during the past years.
Furthermore, the percentage of those with diabetes who are
aware, treated, and controlled is unacceptably low. A national
diabetes education program should be established to promote
community- and clinic-based blood glucose screening.
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